Continuous cerebral administration of FGF-21 for 2 weeks increased whole body insulin sensitivity in rats with dietary-induced obesity [77], whilst daily intravenous or subcutaneous delivery of FGF-21 for 6 weeks improved glucose handling in diabetic rhesus monkeys [78]. This evidence concerns the gene INS and obesity disorder.